Daniella Mehalik
Finanzdirektor/CFO bei PSYCHEMEDICS CORPORATION
Profil
Daniella Mehalik is currently the Vice President-Finance & Treasurer at Psychemedics Corp.
Prior to this, she worked as a Controller at NeuBase Therapeutics, Inc. from 2021 to 2023 and at DxTx Medical, Inc. from 2019 to 2021.
She holds undergraduate and graduate degrees from Carlow University Of.
Aktive Positionen von Daniella Mehalik
Unternehmen | Position | Beginn |
---|---|---|
PSYCHEMEDICS CORPORATION | Finanzdirektor/CFO | 27.11.2023 |
Ehemalige bekannte Positionen von Daniella Mehalik
Unternehmen | Position | Ende |
---|---|---|
NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.01.2023 |
DxTx Medical, Inc. | Comptroller/Controller/Auditor | 01.01.2021 |
Ausbildung von Daniella Mehalik
Carlow University Of | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PSYCHEMEDICS CORPORATION | Health Services |
Private Unternehmen | 2 |
---|---|
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
DxTx Medical, Inc. |